HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White maintains a Buy rating on Aura Biosciences and raises the price target from $21 to $22.
October 18, 2024 | 10:24 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reaffirmed its Buy rating on Aura Biosciences and increased the price target from $21 to $22, indicating positive sentiment and potential upside.
The reaffirmation of a Buy rating and an increase in the price target by a reputable analyst can positively influence investor sentiment and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100